Genes & Cancer · 2011 · 47 citations · 51 references
MedicineMolecular GeneticsOncologyCancer GeneticsMolecular OncologyPediatric OncologyCancer Molecular PathologyGermline Cancer PredispositionMalignant NeoplasmsPediatric Cancer GeneticsPediatric TumorsTumor Suppressor GenesGermline MutationsGermline PredispositionP53 InactivationP53 MutationPediatric Adrenal TumorsTp53 MutationsTumor Suppressor LossTumor Suppressor Pathways
Although the majority of pediatric malignancies express wild-type p53, it is well established that germline TP53 mutations or functional inactivation of this pathway by other means contribute to childhood cancer. Epidemiology studies have revealed the existence of diverse inherited mutant TP53 alleles that display different levels of tumor suppressor activity, which correlate with cancer risk in terms of penetrance, age of onset, and tumor types. In this monograph, the authors describe those childhood cancers associated with functional inactivation of TP53 focusing on adrenocortical carcinoma as a model for tissues that are highly sensitive to loss of p53 activity.
51
Mdm2 promotes the rapid degradation of p53
Ygal Haupt, Ruth Maya, Anat Kazaz et al. · Nature · 1997 · 4.5K citations
Ahmedin Jemal, Thomas S. Murray, Alicia Samuels et al. · CA A Cancer Journal for Clinicians · 2003 · 3.3K citations · Full text
Medicine, Demography, Oncology +17
A cancer family syndrome in twenty-four kindreds.
Frederick P. Li, Joseph F. Fraumeni, J. J. Mulvihill et al. · PubMed · 1988 · 1.3K citations